RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,330.00
-150.00 (-2.74%)
At close: Jul 10, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 46.19 billion as of July 10, 2026. Its market cap has decreased by -6.65% in one year.
Market Cap
46.19B
Enterprise Value
45.71B
Revenue
137.35B
Ranking
n/a
PE Ratio
8.23
Stock Price
5,330.00
Market Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 46.19B, a decrease of -67.74%. That is a compound annual growth rate of -25.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 46.19B | -27.97% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharos iBio | 68.87B |
| Sinsin Pharmaceutical | 67.05B |
| GL Pharm Tech | 65.30B |
| Sinil Pharmaceutical | 60.07B |
| Organoidsciences | 51.70B |
| Jin Yang Pharmaceutical | 50.35B |
| Samik Pharmaceutical Company LTD. | 43.28B |
| GeneBioTech Co. ,Ltd | 39.78B |